Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE GOVERNMENT OF THE UNITED STATES OF AMERICA”

68 pharma patents match "THE GOVERNMENT OF THE UNITED STATES OF AMERICA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 68
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 68 pharmaceutical patents matching "THE GOVERNMENT OF THE UNITED STATES OF AMERICA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

68 results for “THE GOVERNMENT OF THE UNITED STATES OF AMERICA” · 30,257 patents in full index Clear search

  1. US 12186363

    Compositions and methods for dengue virus chimeric constructions in vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted

  2. US 12152242

    CRISPR therapy

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted

  3. US 11986534

    Treatment of anthrax with pegylated capsule-degrading enzyme

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted May 21, 2024 · Expires May 16, 2044

    granted

  4. US 11959096

    Methods for selective inhibition of pluripotent stem cells

    The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services NIH, Office of Technology Transfer · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted

  5. US 11878064

    Nanoparticle/peptide method of blocking potassium channels

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted

  6. US 11865172

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  7. US 11786601

    Pegylated capsule-degrading enzyme for the treatment of anthrax

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  8. US 11744834

    Metal-porphyrin complexes for the inactivation of the biological activity of opioids

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  9. US 11746335

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  10. US 11739137

    Single domain antibodies to SARS-CoV-2 nucleocapsid protein

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  11. US 11617800

    Nanoparticle-enhanced activity of a potassium channel-blocking peptide

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  12. US 11542320

    Nucleic acids encoding single domain antibodies to chikungunya virus

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  13. US 11497803

    Modulation of replicative fitness by deoptimization of synonymous codons

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted

  14. US 11471528

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The Government of the United States of America as represented by the Secretary of the Department · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  15. US 11339387

    Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted May 24, 2022 · Expires May 19, 2042

    granted

  16. US 11332722

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  17. US 11191824

    Method of purifying virus-like-particles

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  18. US 11160859

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  19. US 11154608

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  20. US 11045558

    RPGR gene therapy for retinitis pigmentosa

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  21. US 11041008

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  22. US 11028152

    Single domain antibodies to Chikungunya virus

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  23. US 11008564

    Processing engineered FMDV P1 polypeptide using an alternative TEV protease

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted May 18, 2021 · Expires May 13, 2041

    granted

  24. US 10934360

    Human monoclonal antibodies against EPHA4 and their use

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.